Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-16 Purchase |
2024-05-20 9:33 pm |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
1,724,137 | $2.9 | $4,999,997 | 10,099,279 (Indirect Direct) |
View |
| 2022-01-12 Purchase |
2022-01-14 12:02 pm |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
155,039 | $12.6 | $1,953,491 | 7,075,233 (Indirect Direct) |
View |
| 2020-06-04 Purchase |
2020-06-04 4:04 pm |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
146,382 | $47 | $6,879,954 | 6,447,492 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-24 Option Award |
2025-01-28 8:11 pm |
N/A 2035-01-24 |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
1,677,884 | $0 | 12,317,030 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 09:11 am |
N/A 2034-08-06 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-26 4:31 pm |
N/A 2034-06-24 |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 4:26 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director |
105,263 | $0 | 1,699,253 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:26 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director |
1,004,328 | $0 | 1,699,253 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 9:33 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
344,828 | $2.9 | 10,099,279 (Indirect) |
View |
| 2024-01-25 Option Award |
2024-01-31 5:46 pm |
N/A 2034-01-25 |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
961,371 | $0 | 9,319,579 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 3:43 pm |
N/A 2033-09-07 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 4:08 pm |
N/A 2033-06-21 |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:03 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director |
245,123 | $0 | 245,123 (Direct) |
View |
| 2023-03-22 Option Award |
2023-03-24 8:14 pm |
N/A 2033-03-22 |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
2,277,776 | $0 | 9,353,008 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 3:13 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
160,000 | $5 | 408,693 (Direct) |
View |
| 2022-09-14 Exercise |
2022-09-16 3:13 pm |
2019-10-07 2022-10-07 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
160,000 | $0 | 408,693 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 11:40 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $5 | 248,693 (Direct) |
View |
| 2022-08-31 Exercise |
2022-09-02 11:40 am |
2015-09-01 2022-09-01 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $0 | 248,693 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-29 4:06 pm |
N/A 2032-06-21 |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 9:13 pm |
N/A 2032-06-10 |
Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director |
179,437 | $0 | 698,178 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 3:37 pm |
N/A 2032-06-08 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-03-14 Other(A) |
2022-04-01 5:40 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
4,710,120 | $0 | 14,502,270 (Indirect) |
View |
| 2022-03-14 Other |
2022-03-31 5:27 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
4,710,121 | $0 | 16,495,448 (Indirect) |
View |
Ownership(A) |
2022-03-28 5:30 pm |
N/A N/A |
Ginkgo Bioworks Holdings Inc. | DNA | Belldegrun Arie Director |
0 | $0 | 522,489 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 5:50 pm |
N/A 2032-03-23 |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
1,458,333 | $0 | 1,458,333 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:14 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
20,600 | $0 | 20,600 (Direct) |
View |
| 2021-03-26 Exercise(A) |
2021-06-09 1:47 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $5 | 245,452 (Direct) |
View |
| 2021-03-26 Exercise(A) |
2021-06-09 1:47 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $0 | 245,452 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:41 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-25 08:00 am |
N/A 2030-03-18 |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
379,066 | $0 | 6,920,193 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-25 08:00 am |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
379,066 | $18.22 | 6,920,193 (Direct) |
View |
| 2021-03-24 Exercise |
2021-04-22 5:19 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $5 | 245,452 (Direct) |
View |
| 2021-03-24 Exercise |
2021-04-22 5:19 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $0 | 245,452 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 5:00 pm |
N/A 2031-03-26 |
Allogene Therapeutics Inc. | ALLO | Belldegrun Arie Director |
252,858 | $0 | 6,740,350 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:44 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
253,251 | $16.15 | 2,315,314 (Indirect) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:44 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
8,932,028 | $0 | 2,315,314 (Indirect) |
View |
Ownership |
2020-10-08 7:07 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Belldegrun Arie Director 10% Owner |
0 | $0 | 2,994,889 (Indirect) |
View |
| 2020-06-08 Option Award |
2020-06-10 6:35 pm |
N/A 2030-06-07 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |